Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy
Samantha M. Morrissey, Jun Yan
Trends in cancer (2020) Vol. 6, Iss. 7, pp. 550-558
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Cancer associated-fibroblast-derived exosomes in cancer progression
Chao Li, Adilson Fonseca Teixeira, Hong‐Jian Zhu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 216
Role of tumor microenvironment in cancer progression and therapeutic strategy
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 175
A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication
Yajuan Liu, Cheng Wang
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 164
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 104
Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
Mengke Niu, Yiming Liu, Ming Yi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Wei Zhang, Wenqun Zhong, Beike Wang, et al.
Developmental Cell (2022) Vol. 57, Iss. 3, pp. 329-343.e7
Open Access | Times Cited: 93
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Exosomes in the Diagnosis and Treatment of Renal Cell Cancer
Stergios Boussios, Perry Devo, Iain C. A. Goodall, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14356-14356
Open Access | Times Cited: 43
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32
Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
Hao Wang, Yi Zhang, Hao Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 21
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases
Christian Bailly, Xavier Thuru, Bruno Quesnel
Cancers (2021) Vol. 13, Iss. 12, pp. 3034-3034
Open Access | Times Cited: 97
The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells
Reza Hajihosseini, Leila Asef‐Kabiri, Hassan Yousefi, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 85
A Checkpoint‐Regulatable Immune Niche Created by Injectable Hydrogel for Tumor Therapy
Qian Li, Zhipeng Zhao, Xiaohan Qin, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 37
Closed Access | Times Cited: 80
Extracellular Vesicles as Biomarkers in Cancer Immunotherapy
Matthen Mathew, Mariam Zade, Nadia Mezghani, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2825-2825
Open Access | Times Cited: 79
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
Maria Teresa Di Martino, Caterina Riillo, Francesca Scionti, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1587-1587
Open Access | Times Cited: 71
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Wenjun Xiong, Yang Gao, Wenyi Wei, et al.
Trends in cancer (2021) Vol. 7, Iss. 9, pp. 837-846
Closed Access | Times Cited: 65
Small Extracellular Vesicles: A Novel Avenue for Cancer Management
Yanan Gao, You Qin, Chao Wan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 57
Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer
Ye Li, Zhuo-Kun Chen, Xu Duan, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 9, pp. 1379-1389
Open Access | Times Cited: 54
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 46
Programmable DNA-Fueled Electrochemical Analysis of Lung Cancer Exosomes
Lingjun Sha, Bing Bo, Fan Yang, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 24, pp. 8748-8755
Closed Access | Times Cited: 41
In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy
Hao Ye, Kaiyuan Wang, Jian Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10637-10650
Closed Access | Times Cited: 39
Extracellular vesicle–based drug delivery in cancer immunotherapy
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 11, pp. 2790-2806
Open Access | Times Cited: 39
Recent advances in exosome-based immunotherapy applied to cancer
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top